Correlation Between Inhibikase Therapeutics and Longeveron LLC
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Longeveron LLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Longeveron LLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Longeveron LLC, you can compare the effects of market volatilities on Inhibikase Therapeutics and Longeveron LLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Longeveron LLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Longeveron LLC.
Diversification Opportunities for Inhibikase Therapeutics and Longeveron LLC
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inhibikase and Longeveron is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Longeveron LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longeveron LLC and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Longeveron LLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longeveron LLC has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Longeveron LLC go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Longeveron LLC
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.84 times more return on investment than Longeveron LLC. However, Inhibikase Therapeutics is 1.84 times more volatile than Longeveron LLC. It trades about 0.09 of its potential returns per unit of risk. Longeveron LLC is currently generating about -0.04 per unit of risk. If you would invest 134.00 in Inhibikase Therapeutics on November 2, 2024 and sell it today you would earn a total of 58.00 from holding Inhibikase Therapeutics or generate 43.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Longeveron LLC
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Longeveron LLC |
Inhibikase Therapeutics and Longeveron LLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Longeveron LLC
The main advantage of trading using opposite Inhibikase Therapeutics and Longeveron LLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Longeveron LLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longeveron LLC will offset losses from the drop in Longeveron LLC's long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Longeveron LLC vs. Nutriband | Longeveron LLC vs. Quoin Pharmaceuticals Ltd | Longeveron LLC vs. RenovoRx | Longeveron LLC vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |